It has been reported that sildenafil, a commonly used inhibitor of PDE5, can improve the sexual function in approximately 63% of DM patients, whereas beneficial effects have been observed in approximately 83% of non-diabetic subjects (Fink et al., 2002). Here, PDE5A is linked to diabetes mellitus.